{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:02:18Z","timestamp":1789081338802,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>There is frequent uncertainty in both the precise quantification of risk, and the application of clinical interventions, designed to mitigate increased heritable colorectal cancer (CRC) susceptibility. We evaluated the role of a collaborative specialist multidisciplinary team meeting (MDM) for familial and hereditary CRC, led by the St Mark\u2019s Hospital Centre for Familial Intestinal Cancer specifically in supporting the clinical management of uncertainty. A retrospective thematic analysis of meeting outcomes from inception in June 2020 until March 2023 was performed. Descriptive statistics were employed to ascertain clinicopathological data, clinical queries and whether MDM recommendations were outside the scope of current guidelines. In total 260 cases were discussed from 13 regional institutions. A prior personal history of cancer was present in 215 (82.6%), and a family history of CRC in 107(41.2%) and non-CRC 27(10.4%) cases. In thematic analysis uncertainty related to indications for genetic testing was considered in 148 (56.9%) of cases, with unexplained mismatch repair deficiency (u-dMMR) in 78 (30%) of cases, and resolution of molecular interpretation in 61 (23.5%). Surveillance related queries represented 55 (21.1%), and mainstreaming 29 (11%) of cases. Management was recommended beyond the scope of existing guidelines in 64 (24.6%) cases. This regional hereditary CRC MDM provides clinicians with support in areas of uncertainty in diagnosis and clinical management, supporting clinical decision-making where evidence and clinical guidelines may be limited. This model could be replicated to support complexity in clinical care in other geographical regions or other health conditions.<\/jats:p>","DOI":"10.1007\/s10689-025-00451-1","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:12:06Z","timestamp":1741219926000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Addressing uncertainty in hereditary colorectal cancer: the role of a regional expert multidisciplinary team meeting"],"prefix":"10.1007","volume":"24","author":[{"given":"Avani","family":"Varde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri","family":"McVeigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Cuthill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela F.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"DeSouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Latchford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7918-4003","authenticated-orcid":false,"given":"Kevin J.","family":"Monahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"issue":"2","key":"451_CR1","first-page":"89","volume":"14","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Barsouk A (2019) Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol 14(2):89\u2013103","journal-title":"Prz Gastroenterol"},{"issue":"2","key":"451_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1053\/j.gastro.2019.07.055","volume":"158","author":"EM Stoffel","year":"2020","unstructured":"Stoffel EM, Murphy CC (2020) Epidemiology and mechanisms of the increasing incidence of Colon and rectal cancers in young adults. Gastroenterology 158(2):341\u2013353","journal-title":"Gastroenterology"},{"issue":"3","key":"451_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.23922\/jarc.2021-009","volume":"5","author":"T Hinoi","year":"2021","unstructured":"Hinoi T (2021) Cancer genomic profiling in colorectal cancer: current challenges in subtyping colorectal cancers based on somatic and germline variants. J Anus Rectum Colon 5(3):213\u2013228","journal-title":"J Anus Rectum Colon"},{"key":"451_CR4","doi-asserted-by":"crossref","unstructured":"Mastrodomenico L, Piombino C, Ricco B, Barbieri E, Venturelli M, Piacentini F et al (2023) Personalized systemic therapies in hereditary Cancer syndromes. Genes (Basel).;14(3)","DOI":"10.3390\/genes14030684"},{"key":"451_CR5","doi-asserted-by":"publisher","unstructured":"Jackson L, Weedon MN, Green HD, Mallabar-Rimmer B, Harrison JW, Wood AR et al (2023) Influence of family history on penetrance of hereditary cancers in a population setting. EClinicalMedicine.; 64 102159. Available from: https:\/\/doi.org\/10.1016\/j.eclinm.2023.102159 Available from: https:\/\/dx.doi.org\/10.1016\/j.eclinm.2023.102159","DOI":"10.1016\/j.eclinm.2023.102159"},{"issue":"12","key":"451_CR6","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1038\/s41431-019-0467-5","volume":"27","author":"JMO Ranola","year":"2019","unstructured":"Ranola JMO, Tsai GJ, Shirts BH (2019) Exploring the effect of ascertainment bias on genetic studies that use clinical pedigrees. Eur J Hum Genetics: EJHG 27(12):1800\u20131807","journal-title":"Eur J Hum Genetics: EJHG"},{"key":"451_CR7","doi-asserted-by":"publisher","unstructured":"McVeigh TP, Monahan KJ, Christopher J, West N, Scott M, Murray J et al (2024) Extent of investigation and management of cases of \u2018unexplained\u2019 mismatch repair deficiency (u-dMMR): a UK Cancer Genetics Group consensus. Journal of medical genetics.; 61 (7): 707\u2013715. Available from: https:\/\/doi.org\/10.1136\/jmg-2024-109886 Available from: http:\/\/dx.doi.org\/10.1136\/jmg-2024-109886","DOI":"10.1136\/jmg-2024-109886"},{"key":"451_CR8","unstructured":"NHS England (2023) National Genomic Test Directory. Testing Criteria for Rare and Inherited Disease"},{"issue":"2","key":"451_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/flgastro-2013-100362","volume":"5","author":"KJ Monahan","year":"2014","unstructured":"Monahan KJ, Clark SK (2014) British society of gastroenterology Cancer G. A National survey of hereditary colorectal cancer services in the UK. Frontline Gastroenterol 5(2):130\u2013134","journal-title":"Frontline Gastroenterol"},{"key":"451_CR10","unstructured":"National Institute for Health and Care Excellence (2017) Molecular testing strategies for Lynch syndrome in people with colorectal cancer. NICE. (Clinical guideline [DG27])"},{"issue":"3","key":"451_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/gutjnl-2019-319915","volume":"69","author":"KJ Monahan","year":"2020","unstructured":"Monahan KJ, Bradshaw N, Dolwani S, Desouza B, Dunlop MG, East JE et al (2020) Guidelines for the management of hereditary colorectal cancer from the British society of gastroenterology (BSG)\/Association of coloproctology of great Britain and Ireland (ACPGBI)\/United Kingdom Cancer genetics group (UKCGG). Gut 69(3):411\u2013444","journal-title":"Gut"},{"issue":"12","key":"451_CR12","doi-asserted-by":"publisher","first-page":"e066802","DOI":"10.1136\/bmjopen-2022-066802","volume":"12","author":"MEE Moya","year":"2022","unstructured":"Moya MEE, Guertin JR, Dorval M, Lapointe J, Bouchard K, Nabi H et al (2022) Examining interprofessional collaboration in oncogenetic service delivery models for hereditary cancers: a scoping review protocol. BMJ Open 12(12):e066802","journal-title":"BMJ Open"},{"issue":"7","key":"451_CR13","first-page":"1149","volume":"22","author":"S White","year":"2020","unstructured":"White S, Jacobs C, Phillips J (2020) Mainstreaming genetics and genomics: a systematic review of the barriers and facilitators for nurses and physicians in secondary and tertiary care. Genet Sci 22(7):1149\u20131155","journal-title":"Genet Sci"},{"issue":"1","key":"451_CR14","doi-asserted-by":"publisher","first-page":"e000124","DOI":"10.1136\/bmjonc-2023-000124","volume":"2","author":"KJ Monahan","year":"2023","unstructured":"Monahan KJ, Ryan N, Monje-Garcia L, Armstrong R, Church DN, Cook J et al (2023) The english National Lynch syndrome transformation project: an NHS genomic medicine service alliance (GMSA) programme. BMJ Oncol 2(1):e000124","journal-title":"BMJ Oncol"},{"issue":"7","key":"451_CR15","doi-asserted-by":"publisher","first-page":"8729","DOI":"10.1002\/cam4.5608","volume":"12","author":"T Soukup","year":"2023","unstructured":"Soukup T, Winters D, Chua K, Rowland P, Moneke J, Skolarus TA et al (2023) Evaluation of changes to work patterns in multidisciplinary cancer team meetings due to the COVID-19 pandemic: A National mixed\u2010method survey study. Cancer Med (Malden MA) 12(7):8729\u20138741","journal-title":"Cancer Med (Malden MA)"},{"issue":"10","key":"451_CR16","doi-asserted-by":"publisher","first-page":"e030505","DOI":"10.1136\/bmjopen-2019-030505","volume":"9","author":"I Al Bakir","year":"2019","unstructured":"Al Bakir I, Sebepos-Rogers GM, Burton H, Monahan KJ (2019) Mainstreaming of genomic medicine in gastroenterology, present and future: a nationwide survey of UK gastroenterology trainees. BMJ Open 9(10):e030505","journal-title":"BMJ Open"},{"key":"451_CR17","doi-asserted-by":"crossref","unstructured":"Leclerc J, Vermaut C, Buisine M (2021) Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI\/dMMR Tumors. Cancers.; 13 (3): 467. Available from: doi: 10.3390\/cancers13030467 Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33530449","DOI":"10.3390\/cancers13030467"},{"issue":"5","key":"451_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0022-3999(03)00511-7","volume":"55","author":"MJ Esplen","year":"2003","unstructured":"Esplen MJ, Urquhart C, Butler K, Gallinger S, Aronson M, Wong J (2003) The experience of loss and anticipation of distress in colorectal cancer patients undergoing genetic testing. J Psychosom Res 55(5):427\u2013435","journal-title":"J Psychosom Res"},{"key":"451_CR19","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez A, Roos VH, Navarro M, Pineda M, Caballol B, Moreno L et al (2022) Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome. Clinical gastroenterology and hepatology.; 20 (3): 611\u2013621.e9. Available from: https:\/\/doi.org\/10.1016\/j.cgh.2020.11.002","DOI":"10.1016\/j.cgh.2020.11.002"},{"key":"451_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/gutjnl-2013-306567","volume":"64","author":"A Win","year":"2014","unstructured":"Win A, Buchanan D, Rosty C, MacInnis R, Dowty J, Dite G, Giles G, Southey MC, Young J, Clendenning M et al (2014) Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives. Gut 64:101\u2013110","journal-title":"Gut"},{"key":"451_CR21","doi-asserted-by":"crossref","unstructured":"Hampton JS, Sharp L, Craig D, Rees CJ (2021) Colorectal Cancer Screening and Surveillance for Non-Hereditary High-Risk Groups\u2014Is It Time for a Re-Think? Current treatment options in gastroenterology.; 19 (1): 48\u201367. Available from: doi: 10.1007\/s11938-020-00317-8 Available from: https:\/\/link.springer.com\/article\/10.1007\/s11938-020-00317-8","DOI":"10.1007\/s11938-020-00317-8"},{"key":"451_CR22","doi-asserted-by":"crossref","unstructured":"Caswell-Jin JL, Gupta T, Hall E, Petrovchich IM, Mills MA, Kingham KE,. Racial\/ethnic differences in multiple-gene sequencing results for hereditary cancer risk. Genet Med. 2018;20(2):234-9","DOI":"10.1038\/gim.2017.96"},{"key":"451_CR23","doi-asserted-by":"publisher","unstructured":"Kapiris M, Josephs D, Kulkarni A, Valganon M, De Souza B, Campbell J et al (2019) 29PA retrospective analysis of 66 colorectal cancer cases from Guy\u2019s and St Thomas\u2019 (GSTT) molecular tumour board. Ann Oncol; 30 (Supplement_7) https:\/\/doi.org\/10.1093\/annonc\/mdz413.034","DOI":"10.1093\/annonc\/mdz413.034"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00451-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-025-00451-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00451-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T18:41:43Z","timestamp":1745260903000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-025-00451-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["451"],"URL":"https:\/\/doi.org\/10.1007\/s10689-025-00451-1","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"20 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}